A new Case Management Order (CMO) has been issued for the Allergan breast implant multi-district litigation (MDL). This updated CMO outlines the schedule for case management conferences throughout 2025, with these conferences set to occur once a month starting in February. The first meeting will take place on February 11 at 2:00 pm.
The purpose of case management conferences is to ensure that complex MDL proceedings continue to progress, with the ultimate goal of facilitating a pre-trial settlement. While it is still too early to determine if or when a settlement will occur in the Allergan breast implant MDL, this new CMO marks positive progress toward that objective.